All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
BELITE BIO, INC Last Reported: 12/31/2023 Stock Symbol: BLTE

Business Address

12750 HIGH BLUFF DRIVE SUITE 475

SAN DIEGO , CA US 92130

Mailing Address

12750 HIGH BLUFF DRIVE SUITE 475

SAN DIEGO , CA US 92130
Phone Number: 858-246-6240 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Cash and Cash Equivalents $88,200,000.00 $42,089,000.00 $17,344,000.00 -- --
Accounts Receivable Net Current -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses and Other Current Assets $947,000.00 $716,000.00 $87,000.00 -- --
Total Current Assets $89,940,000.00 $42,807,000.00 $17,431,000.00 -- --
Property Plant and Equipement $490,000.00 $541,000.00 $94,000.00 -- --
Intangible Assets Net -- -- -- -- --
Goodwill -- -- -- -- --
Other Assets -- -- -- -- --
Total Assets $94,642,000.00 $44,273,000.00 $18,348,000.00 -- --
Accounts Payable -- -- -- -- --
Accrued Liabilities $3,325,000.00 $1,906,000.00 $1,564,000.00 -- --
Total Current Liabilities $4,211,000.00 $2,772,000.00 $1,635,000.00 -- --
Long Term Debt -- -- -- -- --
Additional Paid-in Capital -- -- -- -- --
Accumulated Other Comprehensive Loss $-374,000.00 $-392,000.00 $-196,000.00 -- --
Accumulated Deficit $-71,500,000.00 $-39,900,000.00 $-27,200,000.00 $-17,600,000.00 --
Total Stockholders' Equity $90,431,000.00 $41,501,000.00 $-15,093,000.00 $-7,037,000.00 $-3,739,000.00
Controlling Interest in Subsidiaries -- -- -- -- --
Total Liabilities and Equity $94,642,000.00 $44,273,000.00 $18,348,000.00 -- --

Statement of Operations

Date 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Total Revenues -- -- -- -- --
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Research and Development $24,844,000.00 $8,869,000.00 $7,419,000.00 $3,688,000.00 --
Selling, General, and Administrative -- -- -- -- --
Total Operating Expenses $31,668,000.00 $12,821,000.00 $9,797,000.00 $5,743,000.00 --
Loss from Operations $-31,668,000.00 $-12,821,000.00 $-9,797,000.00 $-5,743,000.00 --
Loss Before Income Taxes $-31,623,000.00 $-12,648,000.00 $-9,666,000.00 $-5,752,000.00 --
Earnings Per Share Basic $-1.19 $-0.63 $-1.01 $-0.65 --
Weighted Average Shares Basic 26,593,673 19,976,596 9,569,932 8,790,397 --
Earnings Per Share Diluted $-1.19 $-0.63 $-1.01 $-0.65 --
Weighted Average Shares Diluted 26,593,673 19,976,596 9,569,932 8,790,397 --
Common Stock Shares Authorized 400,000,000 492,179,086 492,179,086 -- --
Common Stock Shares Outstanding 29,149,444 24,898,908 10,274,403 -- --
Common Stock Value $3,000.00 $3,000.00 $1,000.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- --
Preferred Stock Value -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- --
Share Price -- -- -- -- --
Copyright 2024 PursePoor.com